UVEITIS TREATMENT MARKET ANALYSIS

Uveitis Treatment Market, by Treatment Type (Corticosteroids, Immunosuppressant, Monoclonal Antibodies, Cycloplegic Agents, Antibiotics, Antivirals, Antifungal, Analgesics), by Disease type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Pan uveitis), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Aug 2020
Code : CMI1094
Pages :186
Formats :
Excel and PDF
Industry : Medical Devices

Uveitis Treatment MarketSize and Trends

The global uveitis treatment market is estimated to be valued at US$ 710.0 Mn in 2022 and is expected to exhibit a CAGR of 5.3% over the forecast period (2022-2030).

Figure 1. Global Uveitis Treatment Market Share (%), by Disease Type, 2022

High prevalence of uveitis is expected to propel growth of the global uveitis treatment over the forecast period. For instance, an article published in Frontiers in Medicine on September 10, 2021, the Pacific Ocular Inflammation Study found an annual incidence of uveitis of 24.9, while the Northern California study found an incidence of 52.4 cases of uveitis per 100,000 person-years.

Figure 2. Global Uveitis Treatment Market Share (%), by Region, 2022